Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
Cells
|
September 26, 2025
Regional Expression of Dystrophin Gene Transcripts and Proteins in the Mouse Brain
Konstantina Tetorou, Artadokht Aghaeipour, Shunyi Ma, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 8, 2020
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
Haiyan Zhou, Jinhong Meng, Alberto Malerba, et al.
The Journal of Cell Biology
|
May 16, 2002
Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site
Jennifer E Morgan, Jacqueline G Gross, Charles N Pagel, et al.
Human Gene Therapy
|
September 16, 2008
Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integration
Olga Isman, Michael L Roberts, Jennifer E Morgan, et al.
Neuromuscular Disorders : NMD
|
November 23, 2022
CRISPR-mediated correction of skeletal muscle Ca<sup>2+</sup> handling in a novel DMD patient-derived pluripotent stem cell model
Cristina Morera, Jihee Kim, Amaia Paredes-Redondo, et al.
Biomedicines
|
December 23, 2023
Networking to Optimize <i>Dmd</i> exon 53 Skipping in the Brain of <i>mdx52</i> Mouse Model
Mathilde Doisy, Ophélie Vacca, Claire Fergus, et al.
Neurology
|
October 31, 2014
Dystrophin quantification: Biological and translational research implications
Karen Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, et al.
Brain : a Journal of Neurology
|
November 22, 2011
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
Karen Anthony, Sebahattin Cirak, Silvia Torelli, et al.
Lancet (London, England)
|
July 26, 2011
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak, Virginia Arechavala-Gomeza, Michela Guglieri, et al.
Journal of Neuropathology and Experimental Neurology
|
September 9, 2021
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients
Silvia Torelli, Domenic Scaglioni, Valentina Sardone, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
Cells
|
September 26, 2025
Regional Expression of Dystrophin Gene Transcripts and Proteins in the Mouse Brain
Konstantina Tetorou, Artadokht Aghaeipour, Shunyi Ma, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
February 8, 2020
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy
Haiyan Zhou, Jinhong Meng, Alberto Malerba, et al.
The Journal of Cell Biology
|
May 16, 2002
Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site
Jennifer E Morgan, Jacqueline G Gross, Charles N Pagel, et al.
Human Gene Therapy
|
September 16, 2008
Adenovirus-based targeting in myoblasts is hampered by nonhomologous vector integration
Olga Isman, Michael L Roberts, Jennifer E Morgan, et al.
Neuromuscular Disorders : NMD
|
November 23, 2022
CRISPR-mediated correction of skeletal muscle Ca<sup>2+</sup> handling in a novel DMD patient-derived pluripotent stem cell model
Cristina Morera, Jihee Kim, Amaia Paredes-Redondo, et al.
Biomedicines
|
December 23, 2023
Networking to Optimize <i>Dmd</i> exon 53 Skipping in the Brain of <i>mdx52</i> Mouse Model
Mathilde Doisy, Ophélie Vacca, Claire Fergus, et al.
Neurology
|
October 31, 2014
Dystrophin quantification: Biological and translational research implications
Karen Anthony, Virginia Arechavala-Gomeza, Laura E Taylor, et al.
Brain : a Journal of Neurology
|
November 22, 2011
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: implications for clinical trials
Karen Anthony, Sebahattin Cirak, Silvia Torelli, et al.
Lancet (London, England)
|
July 26, 2011
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
Sebahattin Cirak, Virginia Arechavala-Gomeza, Michela Guglieri, et al.
Journal of Neuropathology and Experimental Neurology
|
September 9, 2021
High-Throughput Digital Image Analysis Reveals Distinct Patterns of Dystrophin Expression in Dystrophinopathy Patients
Silvia Torelli, Domenic Scaglioni, Valentina Sardone, et al.
Page
of 8